Grieving parents hold up signs during a news conference, calling for justice for the deaths of children linked to contaminated cough syrups, in Serekunda, Gambia, November 4, 2022. REUTERS/Edward McAllister
![Indian cough syrup: mystery middleman clue](https://cloudfront-us-east-2.images.arcpublishing.com/reuters/PIQCOKC4XNICLKPM7ZGDVT3RTA.jpg)
People stand outside the Maiden Pharmaceuticals plant that was sealed by the Indian government officials in 2022, in Sonipat in the northern state of Haryana, India, February 2, 2023. REUTERS/Adnan Abidi/File Photo
![Indian cough syrup: mystery middleman clue](https://cloudfront-us-east-2.images.arcpublishing.com/reuters/BB3TFBWK4VLBZINLUUPKQ5OMFM.jpg)
Ebrima Saidy shows a picture on his phone of his twin daughters, one of whom, Adama, 3, died of Acute Kidney Injury in September 2022, in Tanji, Gambia, November 3, 2022. REUTERS/Edward McAllister/File Photo
![A woman walks past the closed gate of Goel Pharma Chem, in New Delhi](https://cloudfront-us-east-2.images.arcpublishing.com/reuters/CYVVC43GD5IPFIS7TCFN3ICAF4.jpg)
A woman walks past the closed gate of Goel Pharma Chem, a chemicals trading firm that according to government officials supplied raw ingredients to Maiden Pharmaceuticals whose cough syrups were linked to the deaths of dozens of children in Gambia, in New Delhi, India, April 3, 2023. REUTERS/Anushree Fadnavis
NEW DELHI/LONDON, April 29 (Reuters) – An unnamed middleman in Mumbai provided a crucial raw material used in Indian-made cough syrups that have been linked to the deaths of more than 70 children in Gambia, a chemicals trader involved in the supply chain told Reuters.